They only investigated 124 maternal samples who developed GDM and 248 control subjects and they just measured no more than 20 parameters, including lipids, high-sensitivity C-reactive protein, adiponectin, etc. Despite of those recent progress, few studies have focused on the prediction for GDM with high dimensional electronic medical records (EHRs)15,16. This evidence concerns the gene ADIPOQ and gestational diabetes.